VERAXA Biotech AG (NASDAQ: VRXA) has announced the appointment of Carl von Halem as interim chief financial officer, effective immediately, as the company navigates a leadership transition. Von Halem succeeds Torsten Bürgermeister and will oversee the company's finance function during this period. VERAXA noted that it is in the final stages of discussions with a permanent CFO candidate, who is expected to support the company's next phase of expansion and operational growth. An update on the permanent appointment will be provided in due course.
Von Halem currently serves as chief financial officer of Xlife Sciences and played a key role in VERAXA's public listing. The company highlighted his extensive experience in corporate finance, life sciences, and technology-driven businesses, as well as his familiarity with VERAXA's operations and strategic development, as critical qualifications for leading the finance function during this transition. His appointment ensures continuity in financial leadership as VERAXA advances its pipeline of antibody-based therapeutics.
VERAXA is building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs, and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, the company is rapidly advancing its pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. BiTAC is a registered trademark of VERAXA Biotech GmbH.
Founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology, VERAXA is well-positioned to address significant unmet medical needs. The appointment of an experienced interim CFO like von Halem is expected to provide stability as the company seeks a permanent leader to drive its financial strategy during a critical growth phase.
For more information, visit the company's newsroom at http://nnw.fm/VRXA.
